Furthermore, BRL37344 increased the CD34 expression in neurospheres, but when SK2 activity was pharmacologically blocked by ABC294640, the expression of the stem marker was similar to the control condition (Fig. 5d), leading to the conclusion that SK2 was involved in the potentiation of stemness downstream of β3-AR in NB. Here, ADRB3 is linked to neuroblastoma.